Amendment to Schedule 13D for Lucid Diagnostics Inc.

PAVmed Inc. filed an amendment to its Schedule 13D regarding its ownership of Lucid Diagnostics Inc. common stock. The amendment updates the reporting person's ownership details, including the number of shares held and voting power. PAVmed Inc. holds 38,816,903 shares, representing 28.3% of the outstanding common stock. The filing also details various agreements, including a Voting Agreement, Debt Exchange Agreement, Security and Pledge Agreement, Management Services Agreement, and Payroll and Benefit Expense Reimbursement Agreement. These agreements outline the terms and conditions related to the acquisition, transfer, and voting of the common stock. The amendment highlights the reporting person's significant influence over the issuer due to its substantial ownership stake.